Esketamine, Sulfentanil or/and Remifentanil
ZGuo20200826
Unknown small_molecule active
Quick answer
Esketamine, Sulfentanil or/and Remifentanil for Opioid Analgesic Adverse Reaction is a Unknown program (small_molecule) at Second Affiliated Hospital of Soochow University with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Second Affiliated Hospital of Soochow University
- Indication
- Opioid Analgesic Adverse Reaction
- Phase
- Unknown
- Modality
- small_molecule
- Status
- active